Stockscreener 앱 받기
19.00
18.17%
-4.22
시간 외 거래:
19.20
0.20
+1.05%
전일 마감가:
$23.22
열려 있는:
$16.355
하루 거래량:
4.28M
Relative Volume:
4.82
시가총액:
$540.12M
수익:
$30.43M
순이익/손실:
$-18.15M
주가수익비율:
-27.54
EPS:
-0.69
순현금흐름:
$-9.08M
1주 성능:
-25.37%
1개월 성능:
-30.61%
6개월 성능:
+31.67%
1년 성능:
+47.40%
1일 변동 폭
$15.56
$19.68
1주일 범위
$15.56
$27.27
52주 변동 폭
$9.76
$30.10
Clearpoint Neuro Inc Stock (CLPT) Company Profile
명칭
Clearpoint Neuro Inc
전화
(949) 900-6833
주소
120 S. SIERRA AVENUE, SOLANA BEACH, CA
CLPT을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
CLPT
Clearpoint Neuro Inc
|
19.00 | 660.08M | 30.43M | -18.15M | -9.08M | -0.69 |
|
ABT
Abbott Laboratories
|
123.84 | 214.96B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
98.59 | 149.24B | 19.35B | 2.78B | 3.49B | 1.8696 |
|
SYK
Stryker Corp
|
358.16 | 136.23B | 24.38B | 2.94B | 4.02B | 7.6145 |
|
MDT
Medtronic Plc
|
90.20 | 116.33B | 34.20B | 4.69B | 5.30B | 3.6218 |
|
EW
Edwards Lifesciences Corp
|
83.07 | 48.41B | 5.88B | 1.34B | 577.90M | 2.3455 |
Clearpoint Neuro Inc Stock (CLPT) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-07-25 | 재개 | B. Riley Securities | Buy |
| 2023-10-24 | 개시 | Stifel | Buy |
| 2023-02-16 | 재개 | B. Riley Securities | Buy |
| 2022-04-05 | 재개 | B. Riley Securities | Buy |
| 2021-03-18 | 개시 | Lake Street | Buy |
| 2020-07-17 | 개시 | B. Riley FBR | Buy |
모두보기
Clearpoint Neuro Inc 주식(CLPT)의 최신 뉴스
What margin trends mean for ClearPoint Neuro Inc. stockStock Surge & Verified Short-Term Plans - newser.com
Will ClearPoint Neuro Inc. rebound enough to break evenShare Buyback & Free Verified High Yield Trade Plans - newser.com
What risks investors should watch in ClearPoint Neuro Inc. stockQuarterly Earnings Report & Safe Capital Growth Stock Tips - newser.com
Long term hold vs stop loss in ClearPoint Neuro Inc.Earnings Summary Report & Daily Oversold Stock Bounce Ideas - newser.com
What momentum indicators show for ClearPoint Neuro Inc. stockEntry Point & Long-Term Safe Investment Plans - newser.com
Is ClearPoint Neuro (NASDAQ:CLPT) A Risky Investment? - simplywall.st
What MACD and RSI say about ClearPoint Neuro Inc.July 2025 Catalysts & Free High Accuracy Swing Entry Alerts - newser.com
Top chart patterns to watch in ClearPoint Neuro Inc.2025 Market Outlook & Proven Capital Preservation Tips - newser.com
Why hedge funds are buying ClearPoint Neuro Inc. stockM&A Rumor & High Accuracy Swing Trade Signals - newser.com
How ClearPoint Neuro Inc. stock performs during Fed tightening cyclesPortfolio Risk Report & Real-Time Volume Spike Alerts - newser.com
Will ClearPoint Neuro Inc. stock outperform growth indexes2025 Trading Recap & Fast Gaining Stock Strategy Reports - newser.com
Using economic indicators to assess ClearPoint Neuro Inc. potentialWeekly Trade Analysis & Safe Swing Trade Setups - newser.com
Real time alert setup for ClearPoint Neuro Inc. performanceProduct Launch & Daily Entry Point Alerts - newser.com
Using portfolio simulators with ClearPoint Neuro Inc. includedJuly 2025 Pullbacks & Weekly Chart Analysis and Guides - newser.com
ClearPoint Neuro Inc. stock daily chart insightsWeekly Profit Report & Advanced Swing Trade Entry Alerts - newser.com
Will ClearPoint Neuro Inc. price bounce be sustainable2025 Volume Leaders & Expert Curated Trade Ideas - newser.com
Will ClearPoint Neuro Inc. stock attract more institutional investorsProduct Launch & Low Risk Investment Opportunities - newser.com
Can ClearPoint Neuro Inc. stock hit record highs again2025 Price Momentum & Community Driven Trade Alerts - newser.com
Is ClearPoint Neuro Inc. stock safe for conservative investorsJuly 2025 Sector Moves & Short-Term Swing Trade Alerts - newser.com
ClearPoint Neuro (CLPT) Projected to Post Earnings on Thursday - MarketBeat
Tools to assess ClearPoint Neuro Inc.’s risk profileWeekly Trade Analysis & Low Risk High Reward Trade Ideas - newser.com
ClearPoint Neuro (NASDAQ:CLPT) Trading Down 6%Should You Sell? - MarketBeat
Clearpoint Neuro Inc (CLPT) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.84%
0.40%
자본화:
|
볼륨(24시간):